Switching from Mounjaro to Wegovy

If recent price increases for Mounjaro have affected you, Wegovy (semaglutide) may be a safe and effective alternative when it is clinically appropriate. This page explains why a switch might make sense, what changes to expect, and how we guide you through it at 24 HR Pharmacy. There is a lot of misleading information online about GLP-1 medicines; please read carefully and seek professional advice before making any changes.

 

Why consider switching to Wegovy?

Wegovy is a once-weekly GLP-1 treatment for weight management with strong evidence for meaningful weight loss when used alongside diet and activity changes. It also has evidence for reducing major cardiovascular events in adults with established cardiovascular disease and overweight or obesity. If rising costs or availability issues with Mounjaro are a concern, switching to Wegovy may help you continue your progress with a medication that suits your goals, budget, and tolerability.

 

How our switch process works

At 24 HR Pharmacy, we make the switch only after a clinical review to ensure it is safe and suitable for you.

1. Clinical assessment: A prescriber reviews your medical history, current medicines, contraception and pregnancy plans, previous GLP-1 experience, goals, and side-effects.

2. Timing the first dose: We typically schedule your first Wegovy dose 1-2 weeks after your last Mounjaro dose, or longer if you still have side-effects; your prescriber will advise the exact timing.

3. Start low and go slow: You usually start at 0.25 mg once weekly to reduce gastrointestinal side-effects.

4. Titration plan: If tolerated, doses are usually increased every four weeks to 0.5 mg, then 1.0 mg, then 1.7 mg, and then 2.4 mg as your maintenance dose, as advised by your prescriber.

5. Monitoring and support: We check in regularly, adjust the pace of dose increases if needed, and provide practical tips for managing common side-effects such as nausea or constipation.

 

Wegovy vs Mounjaro: what actually changes?

Mounjaro contains tirzepatide, which targets two receptors (GIP and GLP-1), while Wegovy contains semaglutide, which targets the GLP-1 receptor only. Because they act differently in the body, people can respond differently to each medicine, and doses cannot be converted directly. Some studies show tirzepatide can lead to greater average weight loss than semaglutide, but that does not mean Wegovy will be less effective for you personally; the best choice depends on your goals, medical history, and how you tolerate treatment.

 

Side-effects and self-care tips

The most common side-effects with GLP-1 medicines are nausea, reflux, bloating, constipation or diarrhoea, and they are most likely when the dose is increased. Eating slowly, choosing smaller portions, limiting high-fat foods, staying hydrated, and pausing or delaying dose increases can help. If you have severe or persistent symptoms, contact us. If you develop severe stomach pain, signs of pancreatitis, or symptoms of gallbladder problems, seek urgent medical care.

 

Beware of misinformation

There is a lot of incorrect advice online about switching GLP-1 medicines. You should not attempt to convert a Mounjaro dose to a “matching” Wegovy dose, and you should not start at a higher Wegovy dose just because you tolerated a high dose of Mounjaro. The safest approach is to start Wegovy at the licensed starting dose and increase gradually with clinical supervision. If you read conflicting advice on social media or forums, please speak to a qualified clinician before acting on it.

 

Frequently asked questions

How soon after my last Mounjaro dose can I start Wegovy?
Many patients start Wegovy 1-2 weeks after their last Mounjaro injection, but your prescriber will confirm the timing based on your side-effects and medical history.

 

What dose will I start on?
The licensed dose you will start at is  0.25 mg once weekly and increase roughly every four weeks if you tolerate the medicine.

 

Can I start at a higher Wegovy dose because I was on a high Mounjaro dose?
Starting higher than 0.25 mg is outside the licensed starting guidance for Wegovy and would only be considered in exceptional situations after a prescriber’s review; most people should start at 0.25 mg.

 

Is Wegovy as effective as Mounjaro?
Wegovy is highly effective for many people, and it also has evidence for reducing major cardiovascular events in certain patients. Some studies show tirzepatide can produce greater average weight loss, but the right medicine for you depends on your goals, side-effect profile, and access.

 

What side-effects should I watch for?
Nausea, reflux, constipation or diarrhoea are common, especially when doses increase. Severe abdominal pain or symptoms of gallbladder problems require urgent medical attention.

 

Will I need lifestyle changes as well?
Yes. Wegovy works best when paired with a healthy eating plan, adequate protein, physical activity, and good sleep. Your prescriber can advise on practical steps.

 

Key points to takeaway 

• - Switching to Wegovy should be at the licensed starting dose of 0.25 mg once weekly, then increase gradually if you tolerate it well.

 

• - Because tirzepatide (Mounjaro) and semaglutide (Wegovy) work differently, there is no direct dose equivalence, so you should not try to “match” one dose to the other.

 

• - You should start Wegovy 1-2 weeks after the last Mounjaro injection to avoid overlap and reduce side-effects, but your prescriber will confirm the exact timing for you.

 

• - The right choice is individual and should be made with a qualified healthcare professional.

 

 

Our promise at 24 HR Pharmacy

We only switch treatments when it is safe and in your best interests, and we will never pressure you to change medicines for financial reasons alone. Every switch is reviewed by a prescriber, and your plan is tailored to your medical history, preferences, and goals. If Wegovy is not right for you, we will explain why and discuss alternatives.

 

Read a detailed article by Sehar Shahid on Pharmaceutical Journal.